These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29714621)

  • 1. Comparative User Testing of Australian and UK Over-the-Counter Labels and Leaflets for Diclofenac.
    Tong V; Raynor DK; Aslani P
    Ther Innov Regul Sci; 2018 Jan; 52(1):38-48. PubMed ID: 29714621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing alternative over-the-counter medicine label formats: How do they compare when evaluated by consumers?
    Tong V; Raynor DK; Aslani P
    Res Social Adm Pharm; 2018 Mar; 14(3):248-261. PubMed ID: 28546037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. User testing as a method for identifying how consumers say they would act on information related to over-the-counter medicines.
    Tong V; Raynor DK; Aslani P
    Res Social Adm Pharm; 2017; 13(3):476-484. PubMed ID: 27423784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt and use of spoken and written over-the-counter medicine information: insights into Australian and UK consumers' experiences.
    Tong V; Raynor DK; Aslani P
    Int J Pharm Pract; 2018 Apr; 26(2):129-137. PubMed ID: 28544204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'It's all there in black and white' - or is it? Consumer perspectives on the proposed Australian Medicine Information Box over-the-counter label format.
    Tong V; Raynor DK; Aslani P
    Health Expect; 2016 Aug; 19(4):948-61. PubMed ID: 26230544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review.
    Tong V; Raynor DK; Aslani P
    Int J Clin Pharm; 2014 Oct; 36(5):865-72. PubMed ID: 24980281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumer Opinions on Existing and Proposed Australian Over-the-Counter Medicine Labeling Strategies in Comparison With the Standardized US Drug Facts Label.
    Tong V; Raynor DK; Hamrosi KK; Acharya B; Panchal N; Aslani P
    Ther Innov Regul Sci; 2016 Jul; 50(4):427-435. PubMed ID: 30227019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study.
    Jokanovic N; Aslani P; Carter S; Duong M; Gnjidic D; Jansen J; Le Couteur D; Hilmer S
    BMJ Open; 2019 Dec; 9(12):e033303. PubMed ID: 31831548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting.
    Hasford J; Moore N; Hoye K
    Int J Clin Pharmacol Ther; 2004 Aug; 42(8):415-22. PubMed ID: 15366321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Web-Based Consumer Medication Information: Content and Usability of 4 Australian Websites.
    Raban MZ; Tariq A; Richardson L; Byrne M; Robinson M; Li L; Westbrook JI; Baysari MT
    Interact J Med Res; 2016 Jul; 5(3):e21. PubMed ID: 27443680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readability of over-the-counter medication labels.
    Sansgiry SS; Cady PS; Patil S
    J Am Pharm Assoc (Wash); 1997; NS37(5):522-8. PubMed ID: 9479403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn.
    Ciociola AA; Sirgo MA; Pappa KA; McGuire JA; Fung K
    Am J Ther; 2001; 8(6):387-98. PubMed ID: 11704777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigative model evaluating how consumers process pictorial information on nonprescription medication labels.
    Sansgiry SS; Cady PS
    Health Mark Q; 1997; 14(4):71-90. PubMed ID: 10168485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use.
    Stosic R; Dunagan F; Palmer H; Fowler T; Adams I
    Int J Pharm Pract; 2011 Aug; 19(4):236-45. PubMed ID: 21733011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine.
    Friedman CP; Romeo D; Hinton SS
    Am J Med; 1997 Feb; 102(2A):50-6. PubMed ID: 9217587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer self-selection, safety, and compliance with a novel over-the-counter ibuprofen 600-mg immediate-release and extended-release tablet.
    Paluch E; Jayawardena S; Wilson B; Farnsworth S
    J Am Pharm Assoc (2003); 2016; 56(4):397-404. PubMed ID: 27184785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of use, comprehensibility and clarity of over-the-counter medicine labels: Consumers' perspectives and needs in Taiwan.
    Huang YM; Chen LJ; Hsieh LL; Chan HY; Chen-Liu KCS; Ho YF
    Health Soc Care Community; 2022 Feb; 30(2):753-761. PubMed ID: 33034423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence study of low-dose diclofenac potassium tablet formulations.
    Hinz B; Hug AM; Fotopoulos G; Gold MS
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):643-8. PubMed ID: 19825328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of bilingual product information labels on Spanish-speaking adults' ability to comprehend OTC information.
    Sansgiry SS; Chanda S; Shringarpure GS
    Res Social Adm Pharm; 2007 Dec; 3(4):410-25. PubMed ID: 18082876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actual use of and adherence to ibuprofen 400 mg tablet dosing instructions in a simulated OTC environment
.
    Meeves S; Leyva R; Richardson C; Wilson B; Savastano DM
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):547-557. PubMed ID: 28513425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.